AI Article Synopsis
- - The study presents a case series of 4 cystic fibrosis patients who had previously undergone solid organ transplants and were treated with elexacaftor/tezacaftor/ivacaftor for at least 6 months
- - Data was gathered retrospectively, meaning that researchers looked back at the patients' records rather than conducting a new trial
- - The treatment was generally well tolerated by the patients, who all reported feeling better subjectively after the therapy
Article Abstract
We report a case series of four patients with cystic fibrosis (CF) and previous solid organ transplantation (SOT) receiving elexacaftor/tezacaftor/ivacaftor therapy for 6 months or more. Data was collected retrospectively. The treatment was well tolerated and all patients reported subjective improvements.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ppul.26217 | DOI Listing |
Publication Analysis
Top Keywords
elexacaftor/tezacaftor/ivacaftor therapy
8
patients cystic
8
cystic fibrosis
8
solid organ
8
organ transplantation
8
outcome elexacaftor/tezacaftor/ivacaftor
4
therapy patients
4
fibrosis solid
4
transplantation report
4
report case
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!